NCT06699628View on ClinicalTrials.gov

Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 23, 2024

Primary Completion Date

November 11, 2024

Study Completion Date

November 11, 2024

Conditions
Not Applicable As This is a Mass Balance/pharmacokinetic Study Performed in Healthy SubjectsApathy
Interventions
DRUG

IRL757

IRL757 capsules

Trial Locations (1)

Unknown

CTC Clinical Trial Consultants AB, Uppsala

Sponsors
All Listed Sponsors
lead

Integrative Research Laboratories AB

INDUSTRY

NCT06699628 - Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers | Biotech Hunter | Biotech Hunter